Sinovac's COVID-19 vaccine 78% effective in late-stage trial in Brazil SAO PAULO: A COVID-19 vaccine developed by China's Sinovac Biotech was 78% effective in a late-stage Brazilian trial, a person familiar with the study said on Thursday, moving the shot closer to regulatory approval in South America's biggest...
